Varicella Outbreak Surveillance in Schools in Sentinel Jurisdictions, 2012-2015.


Journal

Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049

Informations de publication

Date de publication:
11 May 2019
Historique:
received: 12 10 2017
accepted: 17 01 2018
pubmed: 10 3 2018
medline: 30 10 2019
entrez: 10 3 2018
Statut: ppublish

Résumé

In 2007, a routine second dose of varicella vaccine was recommended in the United States for children aged 4 to 6 years to better control varicella-zoster virus circulation and outbreaks. Sentinel varicella outbreak surveillance was established to assess feasibility of surveillance and describe outbreaks that are occurring. Through the Centers for Disease Control and Prevention Epidemiology Laboratory Capacity funding, health departments conducted active surveillance for varicella outbreaks in schools from 2012 to 2015. Outbreaks of varicella were defined as ≥5 cases in a school within at least 1 incubation period (21 days). School nurses, healthcare providers, or laboratories reported cases and outbreaks of varicella to health departments; demographic, vaccination, and clinical data were collected. Georgia, Houston, Maine, Minnesota, New York City, and Philadelphia participated in all 3 years; Puerto Rico and West Virginia participated in 2012 to 2013; and Kansas and Arkansas participated in 2014 to 2015. Twenty-nine outbreaks including 262 cases were reported. The median size of the outbreaks was 7 cases (range, 5-31 cases), and the median duration was 31 days (range, 4-100 days). Of the case-patients associated with larger outbreaks (≥8 cases), 55.4% were unvaccinated, and 15.7% and 18.1% had received 1 or 2 doses of vaccine, respectively. In small outbreaks (5-7 cases), 33.3% of case-patients were unvaccinated, and 16.7% and 38.5% had received 1 or 2 doses of vaccine, respectively. The majority of cases associated with outbreaks occurred in undervaccinated children (unvaccinated and 1-dose vaccine recipients). Outbreaks with a greater proportion of 2-dose vaccine recipients were smaller. Varicella outbreak surveillance is feasible, and continued monitoring of outbreaks remains important for describing the epidemiology of varicella during the 2-dose varicella vaccination program.

Sections du résumé

BACKGROUND BACKGROUND
In 2007, a routine second dose of varicella vaccine was recommended in the United States for children aged 4 to 6 years to better control varicella-zoster virus circulation and outbreaks. Sentinel varicella outbreak surveillance was established to assess feasibility of surveillance and describe outbreaks that are occurring.
METHODS METHODS
Through the Centers for Disease Control and Prevention Epidemiology Laboratory Capacity funding, health departments conducted active surveillance for varicella outbreaks in schools from 2012 to 2015. Outbreaks of varicella were defined as ≥5 cases in a school within at least 1 incubation period (21 days). School nurses, healthcare providers, or laboratories reported cases and outbreaks of varicella to health departments; demographic, vaccination, and clinical data were collected.
RESULTS RESULTS
Georgia, Houston, Maine, Minnesota, New York City, and Philadelphia participated in all 3 years; Puerto Rico and West Virginia participated in 2012 to 2013; and Kansas and Arkansas participated in 2014 to 2015. Twenty-nine outbreaks including 262 cases were reported. The median size of the outbreaks was 7 cases (range, 5-31 cases), and the median duration was 31 days (range, 4-100 days). Of the case-patients associated with larger outbreaks (≥8 cases), 55.4% were unvaccinated, and 15.7% and 18.1% had received 1 or 2 doses of vaccine, respectively. In small outbreaks (5-7 cases), 33.3% of case-patients were unvaccinated, and 16.7% and 38.5% had received 1 or 2 doses of vaccine, respectively.
CONCLUSIONS CONCLUSIONS
The majority of cases associated with outbreaks occurred in undervaccinated children (unvaccinated and 1-dose vaccine recipients). Outbreaks with a greater proportion of 2-dose vaccine recipients were smaller. Varicella outbreak surveillance is feasible, and continued monitoring of outbreaks remains important for describing the epidemiology of varicella during the 2-dose varicella vaccination program.

Identifiants

pubmed: 29522133
pii: 4924201
doi: 10.1093/jpids/piy010
doi:

Substances chimiques

Chickenpox Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-127

Informations de copyright

Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2018.

Auteurs

Adriana S Lopez (AS)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Bethany LaClair (B)

Georgia Department of Public Health, Atlanta.

Vicki Buttery (V)

Minnesota Department of Health, St. Paul.

Yufang Zhang (Y)

Houston Health Department, Texas.

Jennifer Rosen (J)

New York City Department of Health and Mental Hygiene, New York.

Elizabeth Taggert (E)

Philadelphia Department of Public Health, Pennsylvania.

Sara Robinson (S)

Maine Department of Health and Human Services, Augusta.

Mychal Davis (M)

Kansas Department of Health and Environment, Topeka.

Catherine Waters (C)

Arkansas Department of Health, Little Rock.

Carrie A Thomas (CA)

West Virginia Department of Health and Human Services, Charleston.

Carmen Rodriguez (C)

Puerto Rico Department of Health, San Juan.

Ebony Thomas (E)

Georgia Department of Public Health, Atlanta.

Jessica Tuttle (J)

Georgia Department of Public Health, Atlanta.

Tamara Brantley (T)

New York City Department of Health and Mental Hygiene, New York.

Dana Perella (D)

Philadelphia Department of Public Health, Pennsylvania.

Maria Del Rosario (M)

West Virginia Department of Health and Human Services, Charleston.

Mona Marin (M)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH